Analytical Biochemistry

分析生物化学

基本信息

  • 批准号:
    9634852
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-02-01 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

The mission of the Analytical Biochemistry Shared Resource is to provide high-quality analytical services to members of the Masonic Cancer Center (MCC) by providing state-of-the-art chromatographic, mass spectrometric, and related techniques, in a timely and cost-efficient manner. The Resource provides • mass spectrometry services • analytical biochemistry services, emphasizing tobacco carcinogen and toxicant biomarker analyses • chromatography services: on-site consulting for the maintenance and service of high-performance liquid chromatography and gas chromatography equipment Stephen Hecht, PhD, the director of Analytical Biochemistry, has many years of experience in analytical organic chemistry and mass spectrometry. Four other staff members also bring decades of experience with mass spectrometry (Dr. Peter Villalta and Brock Matter), nicotine metabolites (Dr. Sharon Murphy), and chromatography (Steven Carmelia). Analytical Biochemistry remains an outstanding and extensively used resource that serves members of almost all of the MCC Programs as well as other researchers at the University. The specialized nature of the facility enables services to be provided at very cost-effective rates, while providing users access to equipment in a timely manner. Most instruments are maintained and repaired by Resource staff, avoiding the need for costly service contracts. Members of the MCC rely on Analytical Biochemistry staff for guidance on related projects, method development, and troubleshooting of instruments. This heavily used and technically outstanding facility continues to provide crucial services to its highly productive users.
分析生物化学共享资源的使命是提供高质量的分析服务

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas Yee其他文献

Douglas Yee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas Yee', 18)}}的其他基金

Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
  • 批准号:
    10412979
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
  • 批准号:
    10625994
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
  • 批准号:
    10028995
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
  • 批准号:
    10171816
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Admin
行政
  • 批准号:
    10474988
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Core B
核心B
  • 批准号:
    10225393
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Admin
行政
  • 批准号:
    10225392
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Core B
核心B
  • 批准号:
    10474991
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Admin
行政
  • 批准号:
    9804094
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Core B
核心B
  • 批准号:
    9804095
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了